172 related articles for article (PubMed ID: 34865079)
1. Prediction of out-of-field recurrence after chemoradiotherapy for cervical cancer using a combination model of clinical parameters and magnetic resonance imaging radiomics: a multi-institutional study of the Japanese Radiation Oncology Study Group.
Ikushima H; Haga A; Ando K; Kato S; Kaneyasu Y; Uno T; Okonogi N; Yoshida K; Ariga T; Isohashi F; Harima Y; Kanemoto A; Ii N; Wakatsuki M; Ohno T
J Radiat Res; 2022 Jan; 63(1):98-106. PubMed ID: 34865079
[TBL] [Abstract][Full Text] [Related]
2. Prediction of outcome using pretreatment
Lucia F; Visvikis D; Desseroit MC; Miranda O; Malhaire JP; Robin P; Pradier O; Hatt M; Schick U
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):768-786. PubMed ID: 29222685
[TBL] [Abstract][Full Text] [Related]
3. MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.
Zhang X; Zhao J; Zhang Q; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
Cancer Imaging; 2022 Jul; 22(1):35. PubMed ID: 35842679
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric magnetic resonance imaging-derived radiomics for the prediction of disease-free survival in early-stage squamous cervical cancer.
Zhou Y; Gu HL; Zhang XL; Tian ZF; Xu XQ; Tang WW
Eur Radiol; 2022 Apr; 32(4):2540-2551. PubMed ID: 34642807
[TBL] [Abstract][Full Text] [Related]
5. MRI-based radiomic signatures for pretreatment prognostication in cervical cancer.
Wagner-Larsen KS; Hodneland E; Fasmer KE; Lura N; Woie K; Bertelsen BI; Salvesen Ø; Halle MK; Smit N; Krakstad C; Haldorsen IS
Cancer Med; 2023 Oct; 12(20):20251-20265. PubMed ID: 37840437
[TBL] [Abstract][Full Text] [Related]
6. Nomograms Combining Clinical and Imaging Parameters to Predict Recurrence and Disease-free Survival After Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
Zhang Y; Liu L; Zhang K; Su R; Jia H; Qian L; Dong J
Acad Radiol; 2023 Mar; 30(3):499-508. PubMed ID: 36050264
[TBL] [Abstract][Full Text] [Related]
7. MRI radiomics in overall survival prediction of local advanced cervical cancer patients tread by adjuvant chemotherapy following concurrent chemoradiotherapy or concurrent chemoradiotherapy alone.
Wei G; Jiang P; Tang Z; Qu A; Deng X; Guo F; Sun H; Zhang Y; Gu L; Zhang S; Mu W; Wang J; Tian J
Magn Reson Imaging; 2022 Sep; 91():81-90. PubMed ID: 35636572
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging features of tumor and lymph node to predict clinical outcome in node-positive cervical cancer: a retrospective analysis.
Park SH; Hahm MH; Bae BK; Chong GO; Jeong SY; Na S; Jeong S; Kim JC
Radiat Oncol; 2020 Apr; 15(1):86. PubMed ID: 32312283
[TBL] [Abstract][Full Text] [Related]
9. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
10. MRI-derived radiomics analysis improves the noninvasive pretreatment identification of multimodality therapy candidates with early-stage cervical cancer.
Li Y; Ren J; Yang JJ; Cao Y; Xia C; Lee EYP; Chen B; Guan H; Qi YF; Gao X; Tang W; Chen K; Jin ZY; He YL; Xiang Y; Xue HD
Eur Radiol; 2022 Jun; 32(6):3985-3995. PubMed ID: 35018480
[TBL] [Abstract][Full Text] [Related]
11. An MRI-based radiomics signature and clinical characteristics for survival prediction in early-stage cervical cancer.
Zheng RR; Cai MT; Lan L; Huang XW; Yang YJ; Powell M; Lin F
Br J Radiol; 2022 Jan; 95(1129):20210838. PubMed ID: 34797703
[TBL] [Abstract][Full Text] [Related]
12. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive prediction of lymph node status for patients with early-stage cervical cancer based on radiomics features from ultrasound images.
Jin X; Ai Y; Zhang J; Zhu H; Jin J; Teng Y; Chen B; Xie C
Eur Radiol; 2020 Jul; 30(7):4117-4124. PubMed ID: 32078013
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images.
Cusumano D; Russo L; Gui B; Autorino R; Boldrini L; D'Erme L; Persiani S; Catucci F; Broggi S; Panza G; Nardangeli A; Campitelli M; Ferrandina G; Macchia G; Fiorino C; Valentini V; Scambia G; Manfredi R; Gambacorta MA
Radiother Oncol; 2022 Sep; 174():30-36. PubMed ID: 35811004
[TBL] [Abstract][Full Text] [Related]
15. IVIM-DWI and MRI-based radiomics in cervical cancer: Prediction of concurrent chemoradiotherapy sensitivity in combination with clinical prognostic factors.
Zhang Y; Zhang K; Jia H; Xia B; Zang C; Liu Y; Qian L; Dong J
Magn Reson Imaging; 2022 Sep; 91():37-44. PubMed ID: 35568271
[TBL] [Abstract][Full Text] [Related]
16. Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy.
Zhang Q; Guo J; Ouyang H; Chen S; Zhao X; Yu X
Eur Radiol; 2022 Apr; 32(4):2529-2539. PubMed ID: 34647177
[TBL] [Abstract][Full Text] [Related]
17. Preoperative prediction of cervical cancer survival using a high-resolution MRI-based radiomics nomogram.
Li J; Zhou H; Lu X; Wang Y; Pang H; Cesar D; Liu A; Zhou P
BMC Med Imaging; 2023 Oct; 23(1):153. PubMed ID: 37821840
[TBL] [Abstract][Full Text] [Related]
18. MRI-based radiomics for pretreatment prediction of response to concurrent chemoradiotherapy in locally advanced cervical squamous cell cancer.
Zhang X; Zhang Q; Chen Y; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
Abdom Radiol (NY); 2023 Jan; 48(1):367-376. PubMed ID: 36222869
[TBL] [Abstract][Full Text] [Related]
19. MRI-based radiomics features for the non-invasive prediction of FIGO stage in cervical carcinoma: A multi-center study.
Liu Y; Dong TF; Li PJ; Chen LB; Song T
Magn Reson Imaging; 2024 Jul; 110():170-175. PubMed ID: 38035947
[TBL] [Abstract][Full Text] [Related]
20. Radiomics analysis of magnetic resonance imaging improves diagnostic performance of lymph node metastasis in patients with cervical cancer.
Wu Q; Wang S; Chen X; Wang Y; Dong L; Liu Z; Tian J; Wang M
Radiother Oncol; 2019 Sep; 138():141-148. PubMed ID: 31252296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
